Investors

FSD is a specialty, biotech pharmaceutical R&D company that aims to deliver growth and returns to shareholders through the development of innovative pharmaceutical products that target the human endocannabinoid system.

Shareholder Information

CLASS A SHARES – ISSUED & OUTSTANDING

CLASS B SUBORDINATE VOTING SHARES

CUSIP
35954B206

ISIN
CA35954B2066

Capital Structure – Issued & Outstanding Basic
7,905,727

Capital Structure – Issued & Outstanding Fully Diluted
9,516,008

CORPORATE GOVERNANCE

Code of Conduct and Ethics

CSE Symbol:

Class B Subordinate Voting Shares

HUGE

Investor Contact Details

The FSD investor relations team responds to requests from professional members of the financial community.

[email protected]

Events & Presentations

Annual General Meeting

Date: Monday December 16, 2019
Time: 10:00 a.m. Eastern
Location: Bennett Jones LLP, 100 King Street West, First Canadian Place, Suite 3400, M5X 1A4

AGM Materials

Form of Proxy
AGSM Circular

12th Annual LD Micro Main Event Investor Conference

Date: Wednesday December 11, 2019
Time: 12:20 pm PT/3:30 pm ET
Location: Luxe Sunset Boulevard Hotel, Los Angeles
Presenter: Dr. Edward Brennan, President, BioSciences Division

Investor Summit

Date: December 17, 2019
Time: 2:35 pm ET
Location: Kimpton Hotel Monaco, Philadelphia
Presenter: Dr. Raza Bokhari, Executive Co-Chairman and Chief Executive Officer
Webcast (live and archived for 1 year): https://www.webcaster4.com/Webcast/Page/2038/32606